Sutro BiopharmaSTRO
那斯達克 · USD
20.49
-0.55
(-2.61%)
收盤 08/25 03:59 (UTC+8)
08/25 03:59 (UTC+8)
Sutro BiopharmaSTRO
20.49
-0.55
(-2.61%)
財務數據
損益表
- 0.13
- 0.26
- 0.09
- 0.15
- 0.17
- 0.64
- 0.10
- 0.12
- 0.15
- 0.10
- -88.56
- 97.62
- -66.86
- 73.81
- 17.49
- 266.37
- -84.79
- 20.16
- 24.69
- -32.25
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 9,839 | 14,523 | 11,647 | 9,693 | 63,745 | 17,399 | 14,809 | 8,520 | 25,706 | 13,008 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 9,839 | 14,523 | 11,647 | 9,693 | 63,745 | 17,399 | 14,809 | 8,520 | 25,706 | - |
營業費用 | 39,727 | 44,179 | 49,696 | 58,152 | 67,090 | 85,913 | 80,067 | 76,439 | 74,391 | - |
研發費用 | 31,695 | 36,553 | 36,642 | 39,853 | 38,325 | 51,597 | 71,037 | 62,108 | 62,020 | 56,878 |
推銷及管理費用 | 7,831 | 7,584 | 8,662 | 8,741 | 10,343 | 13,273 | 9,030 | 14,331 | 12,371 | 12,721 |
非經常性項目費用 | 201 | 42 | 4,392 | 9,558 | 18,422 | 21,043 | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -29,888 | -29,656 | -38,049 | -48,459 | -3,345 | -68,514 | -65,258 | -67,919 | -48,685 | -56,591 |
其他收入及費用 | 1,218 | 624 | 752 | 1,272 | 1,475 | 1,890 | 3,860 | 35,529 | 3,153 | 1,883 |
利息費用 | 9,862 | 9,467 | 9,547 | 9,670 | 9,647 | 9,344 | 8,690 | 7,910 | 7,286 | 7,184 |
稅前純益 | -38,532 | -38,499 | -46,844 | -56,857 | -11,517 | -75,968 | -70,088 | -48,787 | -44,331 | -58,213 |
所得稅 | 1 | -15 | -82 | - | -18 | - | 2,355 | - | 8 | - |
稅後純益 | -38,533 | -38,484 | -46,762 | -56,857 | -11,499 | -75,968 | -72,443 | -48,787 | -48,018 | -58,213 |
基本每股稅後盈餘(元) | -2.33 | -2.94 | -20.77 | -0.67 | -0.14 | -0.91 | -0.83 | -0.59 | -0.59 | -0.95 |
稀釋每股稅後盈餘(元) | -2.25 | -2.94 | -5.39 | -0.68 | -0.12 | -0.91 | -0.87 | -0.58 | -0.54 | -0.95 |
基本平均股數(千股) | 16571.00 | 13082.00 | - | 84869.00 | 84580.00 | 83642.00 | 82592.00 | 82043.00 | 81224.00 | 61457.00 |
稀釋平均股數(千股) | 16571.00 | 13082.00 | - | 84869.00 | 84580.00 | 83642.00 | 82592.00 | 82043.00 | 81224.00 | 61457.00 |
還原基本每股稅後盈餘(元) | -2.33 | -2.94 | -20.77 | -6.70 | -1.40 | -9.08 | -8.30 | -5.90 | -5.90 | -9.50 |
還原稀釋每股稅後盈餘(元) | -2.25 | -2.94 | -5.39 | -6.79 | -1.23 | -9.08 | -8.70 | -5.80 | -5.40 | -9.50 |
還原基本平均股數(千股) | 16,571 | 13,082 | - | 8,486 | 8,458 | 8,364 | 8,259 | 8,204 | 8,122 | 6,145 |
還原稀釋平均股數(千股) | 16,571 | 13,082 | - | 8,486 | 8,458 | 8,364 | 8,259 | 8,204 | 8,122 | 6,145 |
EBITDA(千元) | -27,861 | -28,199 | -36,204 | -46,042 | -1,003 | -65,840 | -61,069 | -41,775 | -41,761 | -51,924 |